Zai Lab (ZLAB) Interest & Investment Income (2020 - 2026)
Zai Lab recorded quarterly Interest & Investment Income of $6.4 million in Q1 2026, down 11.12% quarter-over-quarter from $7.3 million in Q4 2025, and down 25.09% year-over-year from $8.6 million in Q1 2025.
Zai Lab's Interest & Investment Income history runs 7 years deep, the most recent figure standing at $6.4 million for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 25.09% year-over-year to $6.4 million; the TTM figure through Mar 2026 stood at $30.9 million (down 14.32% YoY), while the FY2025 annual figure was $33.0 million, down 10.93% from the prior year.
- Interest & Investment Income came in at $6.4 million for Q1 2026 at Zai Lab, down from $7.3 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $10.3 million in Q4 2023 to a low of $188000.0 in Q1 2022.
- A 5-year average of $7.7 million and a median of $9.0 million in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income jumped 5342.55% in 2023 and slipped 25.09% in 2026, its largest moves.
- Zai Lab's Interest & Investment Income stood at $9.3 million in 2022, then increased by 10.24% to $10.3 million in 2023, then dropped by 11.8% to $9.1 million in 2024, then decreased by 20.18% to $7.3 million in 2025, then dropped by 11.12% to $6.4 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $6.4 million, $7.3 million, and $8.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Zai Lab | 19.59 Bn | 19.49 Bn | 61.30 Mn | 6.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.45 Mn |
| Dec 31, 2025 | 7.25 Mn |
| Sep 30, 2025 | 8.35 Mn |
| Jun 30, 2025 | 8.84 Mn |
| Mar 31, 2025 | 8.61 Mn |
| Dec 31, 2024 | 9.09 Mn |
| Sep 30, 2024 | 9.03 Mn |
| Jun 30, 2024 | 9.33 Mn |
| Mar 31, 2024 | 9.66 Mn |
| Dec 31, 2023 | 10.30 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 10.09 Mn |
| Mar 31, 2023 | 10.23 Mn |
| Dec 31, 2022 | 9.35 Mn |
| Sep 30, 2022 | 3.87 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 188,000.00 |
| Dec 31, 2021 | 1.02 Mn |
| Sep 30, 2021 | 713,000.00 |
| Jun 30, 2021 | 244,000.00 |
| Mar 31, 2021 | 214,000.00 |
| Dec 31, 2020 | 1.37 Mn |
| Sep 30, 2020 | 866,000.00 |
| Jun 30, 2020 | 1.23 Mn |
| Mar 31, 2020 | 1.66 Mn |